# Alto Neuroscience (ANRO) — Earnings

ANRO · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/anro/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.65 |
| EPS estimate | −$0.60 |
| EPS surprise | −8.59% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 13, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1999480/000199948025000076/alto-20250630.htm) |

Alto Neuroscience's most recent results in the table are for Q2 2025, reported on August 13, 2025. The company posted a loss of $0.65 per share, wider than the $0.60 loss analysts expected, a miss of 8.59%. A year earlier, in Q2 2024, the loss was $0.60 per share, so the quarterly loss widened by about 8%. No revenue figures or revenue estimates are given for any quarter.

The record here is short: four quarters, Q2 2024, Q4 2024, Q1 2025 and Q2 2025, with no row for Q3 2024. Every quarter shown is a loss, ranging from $0.52 per share in Q4 2024 to $0.65 in Q2 2025. The loss has widened in each quarter since Q4 2024, from $0.52 to $0.56 and then $0.65. Alto beat the EPS estimate three times out of four, by 19.48% in Q4 2024, 8.63% in Q2 2024 and 7.99% in Q1 2025. There are too few quarters for full-year totals.

The table ends at Q2 2025 and has no later quarter. Past report dates fell in late March, mid-May and mid-August. When newer quarters are added, they will show whether the per-share loss kept widening or eased.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 13, 2025 | −$0.60 | −$0.65 | -8.59% | — | — |
| Q1 2025 | May 14, 2025 | −$0.61 | −$0.56 | 7.99% | — | — |
| Q4 2024 | Mar 20, 2025 | −$0.65 | −$0.52 | 19.48% | — | — |
| Q2 2024 | Aug 13, 2024 | −$0.66 | −$0.60 | 8.63% | — | — |

## Frequently Asked Questions

### When did Alto Neuroscience (ANRO) last report earnings?

Alto Neuroscience last reported on Aug 13, 2025, covering fiscal Q2 2025.

### Did ANRO beat earnings estimates?

No. Alto Neuroscience reported EPS of −$0.65 for Q2 2025 against a −$0.60 estimate — a 8.59% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).